Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: the special case of molnupiravir

MD Waters, S Warren, C Hughes… - Environmental and …, 2022 - Wiley Online Library
This review considers antiviral nucleoside analog (NA) drugs, including ribavirin, favipiravir,
and molnupiravir, which induce genome error catastrophe in SARS‐CoV or SARS‐CoV‐2 …

Chemical-induced DNA damage and human cancer risk

MC Poirier - Nature Reviews Cancer, 2004 - nature.com
Chemical carcinogenesis involves a complex series of events, the earliest of which typically
include DNA damage and the fixation of DNA mutations. Sophisticated new techniques have …

In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections

L Yang, JAJ Haagensen, L Jelsbak, HK Johansen… - 2008 - Am Soc Microbiol
The growth dynamics of bacterial pathogens within infected hosts are a fundamental but
poorly understood feature of most infections. We have focused on the in situ distribution and …

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants

GK Siberry, PL Williams, H Mendez, GR Seage III… - Aids, 2012 - journals.lww.com
Objective: To evaluate the association of tenofovir disoproxil fumarate (TDF) use during
pregnancy with early growth parameters in HIV-exposed, uninfected (HEU) infants. Design …

[HTML][HTML] The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs

RB Van Dyke, EG Chadwick, R Hazra… - Frontiers in …, 2016 - frontiersin.org
The Surveillance Monitoring for ART Toxicities (SMARTT) cohort of the Pediatric HIV/AIDS
Cohort Study includes over 3,500 HIV-exposed but uninfected infants and children at 22 …

Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors

OA Olivero - Environmental and molecular mutagenesis, 2007 - Wiley Online Library
Nucleoside analogs were first approved by the US Food and Drug Administration for use
against HIV‐AIDS in 1987. Since then, these agents, now commonly referred to as …

Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead

R Smith, M Wilkins - Child Neuropsychology, 2015 - Taylor & Francis
Over the past three decades, perinatal HIV infection in the United States has evolved from a
fatal disease to a manageable chronic illness. As the majority of youth with perinatal HIV …

Lung cancer in HIV infected patients: facts, questions and challenges

J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron… - Thorax, 2006 - thorax.bmj.com
AIDS related mortality has fallen sharply in industrialised countries since 1996 following the
introduction of highly active antiretroviral therapy. This has been accompanied by an …

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants

PL Williams, M Marino, K Malee, S Brogly… - …, 2010 - publications.aap.org
OBJECTIVE: Antiretroviral (ARV) drugs are routinely provided to HIV-infected pregnant
women to prevent HIV mother-to-child transmission. Although ARV use has significantly …

Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children

S Heidari, L Mofenson, MF Cotton… - JAIDS Journal of …, 2011 - journals.lww.com
The provision of antiretroviral drugs for the prevention of mother-to-child HIV transmission
has been rising sharply in low-and middle-income countries. Changes to the World Health …